MyFinsight
Home
Blog
About
Short-term marketable
securities
$156,087K
(-2.02%↓ Y/Y)
Cash and cash
equivalents
$33,419K
(-25.42%↓ Y/Y)
Prepaid expenses and
other current assets
$7,579K
(-25.99%↓ Y/Y)
Accounts receivable
$6,534K
(-21.59%↓ Y/Y)
Total current assets
$203,619K
(-8.57%↓ Y/Y)
Operating lease,
right-of-use assets
$35,852K
(-6.27%↓ Y/Y)
Property and equipment,
net
$31,942K
(-12.77%↓ Y/Y)
Long-term marketable
securities
$21,987K
Long-term restricted cash
$3,360K
(0.00%↑ Y/Y)
Other long-term
assets
$110K
(17.02%↑ Y/Y)
Total assets
$296,870K
(-1.38%↓ Y/Y)
Total liabilities and
stockholders' equity
$296,870K
(-1.38%↓ Y/Y)
Total liabilities
$195,802K
(-11.70%↓ Y/Y)
Total stockholders'
equity
$101,068K
(27.48%↑ Y/Y)
Accumulated deficit
-$449,459K
(-16.37%↓ Y/Y)
Accumulated other
comprehensive loss
-$927K
(-130.60%↓ Y/Y)
Liability related to the
sale of future...
$88,289K
(-26.39%↓ Y/Y)
Total current
liabilities
$54,166K
(21.59%↑ Y/Y)
Operating lease
liabilities, net of current...
$51,750K
(-7.02%↓ Y/Y)
Series 1
nonconvertible preferred stock
$1,311K
(-2.89%↓ Y/Y)
Other long-term
liabilities
$286K
(13.49%↑ Y/Y)
Additional paid-in capital
$551,163K
(18.35%↑ Y/Y)
Common stock 0.01 par
value per share,...
$291K
(35.98%↑ Y/Y)
Liability related to the
sale of future...
$36,784K
(32.53%↑ Y/Y)
Accrued expenses and
other current...
$10,183K
(-6.17%↓ Y/Y)
Operating lease
liabilities
$3,906K
(63.16%↑ Y/Y)
Accounts payable
$3,293K
(-7.16%↓ Y/Y)
Back
Back
Balance Sheet
ENANTA PHARMACEUTICALS INC (ENTA)
ENANTA PHARMACEUTICALS INC (ENTA)
source: myfinsight.com